Literature DB >> 32266104

The association and joint effect of serum cholesterol, glycemic status with the risk of incident cancer among middle-aged and elderly population in china cardiometabolic disease and cancer cohort (4C)-study.

Mian Li1, Jieli Lu1, Jing Fu2, Qin Wan3, Tiange Wang1, Yanan Huo4, Yu Xu1, Min Xu1, Zhiyun Zhao1, Yuhong Chen1, Shuangyuan Wang1, Guijun Qin5, Yingfen Qin6, Ruying Hu7, Xulei Tang8, Guixia Wang9, Feixia Shen10, Zuojie Luo6, Li Chen11, Qing Su12, Xuefeng Yu13, Li Yan14, Gang Chen15, Zhengnan Gao16, Yinfei Zhang17, Chao Liu18, Youmin Wang19, Shengli Wu20, Tao Yang21, Qiang Li22, Yiming Mu23, Jiajun Zhao24, Lulu Chen25, Lixin Shi26, Guang Ning1, Yufang Bi1, Hongyang Wang2, Weiqing Wang1.   

Abstract

The associations between different combinations of metabolic abnormalities and the risk of all and site-specific cancers remain unclear. We aimed to estimate the association and interplay between serum cholesterol, glycemic status and risk of cancer in the China Cardiometabolic Disease and Cancer Cohort (4C)-Study, a nationwide, multicenter, prospective, population-based study. The investigation was performed in 137,884 participants during 2014-2016. Incident cancer was defined as the first occurrence of any type cancer of all sites during follow-up. After 510,164 person-years of follow-up, 1,710 were detected as incident cancer after exclusion of participants diagnosed as cancer within 6 months from baseline. A relatively low level of LDL cholesterol (<100 mg/dl) was related to a significant higher risk of incident cancer [1.20 (1.08-1.34); P=0.0007]. Diabetic individuals have a significantly higher risk of incident cancer, especially those with poorly glycemic control. Diabetic participants with both lower levels of LDL cholesterol and poorly glycemic control were at a higher risk of incident cancer [1.42 (1.10-1.81); P=0.006]. Our study showed a positive association of cancer risk with low-level LDL cholesterol and diabetes and found that participants with both lower levels of LDL cholesterol and poorly controlled diabetes had the higher risk of incident cancer, which indicates the compelling need of achieving glycemic control goal and maintaining appropriate LDL cholesterol levels. AJCR
Copyright © 2020.

Entities:  

Keywords:  Cancer; HbA1c; LDL; cholesterol; diabetes

Year:  2020        PMID: 32266104      PMCID: PMC7136907     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  35 in total

1.  Statin use and reduced cancer-related mortality.

Authors:  Sune F Nielsen; Børge G Nordestgaard; Stig E Bojesen
Journal:  N Engl J Med       Date:  2012-11-08       Impact factor: 91.245

Review 2.  Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies.

Authors:  Konstantinos K Tsilidis; John C Kasimis; David S Lopez; Evangelia E Ntzani; John P A Ioannidis
Journal:  BMJ       Date:  2015-01-02

Review 3.  Drug-subphenotype interactions for cancer in type 2 diabetes mellitus.

Authors:  Xilin Yang; Heung M Lee; Juliana C N Chan
Journal:  Nat Rev Endocrinol       Date:  2015-03-24       Impact factor: 43.330

4.  Low LDL cholesterol, albuminuria, and statins for the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry.

Authors:  Xilin Yang; Wing Yee So; Ronald C W Ma; Gary T C Ko; Alice P S Kong; Hailu Zhao; Andrea O Y Luk; Christopher W K Lam; Chung Shun Ho; Peter C Y Tong; Juliana C N Chan
Journal:  Diabetes Care       Date:  2009-07-10       Impact factor: 19.112

5.  Excessive Weight Gain, Obesity, and Cancer: Opportunities for Clinical Intervention.

Authors:  Greta M Massetti; William H Dietz; Lisa C Richardson
Journal:  JAMA       Date:  2017-11-28       Impact factor: 56.272

6.  Effect of plasma lipoproteins on natural killer cell activity in the elderly population.

Authors:  Tomiya Yasumasu; Kazuo Takahara; Takao Sadayasu; Hirokazu Date; Kazuhiko Isozumi; Ryouji Kouzuma; Yasuhide Nakashima
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2003-06       Impact factor: 6.053

Review 7.  Adiposity and cancer at major anatomical sites: umbrella review of the literature.

Authors:  Maria Kyrgiou; Ilkka Kalliala; Georgios Markozannes; Marc J Gunter; Evangelos Paraskevaidis; Hani Gabra; Pierre Martin-Hirsch; Konstantinos K Tsilidis
Journal:  BMJ       Date:  2017-02-28

8.  Diabetes, plasma glucose and incidence of pancreatic cancer: A prospective study of 0.5 million Chinese adults and a meta-analysis of 22 cohort studies.

Authors:  Yuanjie Pang; Christiana Kartsonaki; Yu Guo; Fiona Bragg; Ling Yang; Zheng Bian; Yiping Chen; Andri Iona; Iona Y Millwood; Jun Lv; Canqing Yu; Junshi Chen; Liming Li; Michael V Holmes; Zhengming Chen
Journal:  Int J Cancer       Date:  2017-02-08       Impact factor: 7.396

Review 9.  Exploring vitamin D metabolism and function in cancer.

Authors:  Sang-Min Jeon; Eun-Ae Shin
Journal:  Exp Mol Med       Date:  2018-04-16       Impact factor: 8.718

10.  Cancer risk associated with chronic diseases and disease markers: prospective cohort study.

Authors:  Huakang Tu; Chi Pang Wen; Shan Pou Tsai; Wong-Ho Chow; Christopher Wen; Yuanqing Ye; Hua Zhao; Min Kuang Tsai; Maosheng Huang; Colin P Dinney; Chwen Keng Tsao; Xifeng Wu
Journal:  BMJ       Date:  2018-01-31
View more
  4 in total

1.  Association between baseline LDL-C and prognosis among patients with coronary artery disease and advanced kidney disease.

Authors:  Bo Wang; Shiqun Chen; Jin Liu; Yan Liang; Liangguang Meng; Xiaoming Yan; Haozhang Huang; Guanzhong Chen; Zhidong Huang; Danyuan Xu; Min Li; Jingjing Liang; Shuangxin Liu; Jiyan Chen; Yong Liu; Ning Tan
Journal:  BMC Nephrol       Date:  2021-05-06       Impact factor: 2.388

2.  Serum lipid profiles and risk of colorectal cancer: a prospective cohort study in the UK Biobank.

Authors:  Zhe Fang; Mingming He; Mingyang Song
Journal:  Br J Cancer       Date:  2020-11-03       Impact factor: 7.640

Review 3.  Dietary Fats, Serum Cholesterol and Liver Cancer Risk: A Systematic Review and Meta-Analysis of Prospective Studies.

Authors:  Longgang Zhao; Chuanjie Deng; Zijin Lin; Edward Giovannucci; Xuehong Zhang
Journal:  Cancers (Basel)       Date:  2021-03-30       Impact factor: 6.639

4.  Score for Predicting Active Cancer in Patients with Ischemic Stroke: A Retrospective Study.

Authors:  Jiwei Jiang; Xiuli Shang; Jinming Zhao; Meihui Cao; Jirui Wang; Runzhi Li; Yanli Wang; Jun Xu
Journal:  Biomed Res Int       Date:  2021-05-25       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.